| 1 |
Lawrence M. Human iPS Cells for Clinical Applications and Cellular Products. Handb Exp Pharmacol 2023. [PMID: 36964256 DOI: 10.1007/164_2023_643] [Reference Citation Analysis]
|
| 2 |
Marrone PV, Mathias FR, Bernardo WM, Orlandini MF, Serafim MCA, Scoton MLRPD, Lopes JM, Pereira SL, Dias EM. Decision Criteria for Partial Nationalization of Pharmaceutical Supply Chain: A Scoping Review. Economies 2023;11:25. [DOI: 10.3390/economies11010025] [Reference Citation Analysis]
|
| 3 |
Thielen FW, Heine RJSD, Berg SVD, Ham RMTT, Groot CAU. Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma. Cytotherapy 2022;24:1245-58. [PMID: 36216697 DOI: 10.1016/j.jcyt.2022.09.002] [Reference Citation Analysis]
|
| 4 |
Kim JH, Kawase E, Bharti K, Karnieli O, Arakawa Y, Stacey G. Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies. NPJ Regen Med 2022;7:54. [PMID: 36175440 DOI: 10.1038/s41536-022-00242-7] [Reference Citation Analysis]
|
| 5 |
Cross N, van Steen C, Zegaoui Y, Satherley A, Angelillo L. Current and Future Treatment of Retinitis Pigmentosa. OPTH 2022;Volume 16:2909-2921. [DOI: 10.2147/opth.s370032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 6 |
Lee E, Shah D, Porteus M, Wright JF, Bacchetta R. Design of experiments as a decision tool for cell therapy manufacturing. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2022.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Ajit A, Ambika Gopalankutty I. Adipose-derived stem cell secretome as a cell-free product for cutaneous wound healing. 3 Biotech 2021;11:413. [PMID: 34476171 DOI: 10.1007/s13205-021-02958-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 8 |
Bonaventura G, Munafò A, Bellanca CM, La Cognata V, Iemmolo R, Attaguile GA, Di Mauro R, Di Benedetto G, Cantarella G, Barcellona ML, Cavallaro S, Bernardini R. Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? Cells 2021;10:1992. [PMID: 34440761 DOI: 10.3390/cells10081992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
